Measuring the Economic Costs of Antimicrobial Resistance in Hospital Settings: Summary of the Centers for Disease Control and Prevention—Emory Workshop

Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2001-11, Vol.33 (9), p.1573-1578
Main Authors: Weinstein, Robert A., Howard, David, Cordell, Ralph, McGowan, John E., Packard, Randall M., Scott, R. Douglas, Solomon, Steven L.
Format: Article
Language:English
Subjects:
Antibacterial agents
Antibiotic resistance
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimicrobials
Biological and medical sciences
Centers for Disease Control and Prevention (U.S.)
Cost estimates
Costs and Cost Analysis
Drug Resistance
Economic costs
Epidemiology
Health care costs
Health outcomes
Healthcare Epidemiology
Hospital costs
Hospital Costs - standards
Humans
Infections
Marginal costs
Medical sciences
Pharmacology. Drug treatments
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yielded widely variable and often conflicting estimates. This lack of reproducibility is largely attributable to problems in study design and in the methods used to identify and measure costs. Addressing these methodological issues was the focus of a workshop that included participants from a broad range of backgrounds, including economics, epidemiology, health care management, health care outcomes research, and clinical care. This workshop summary presents the advantages and disadvantages of various research designs as well as particular methodological issues related to the measurement of the economic cost of resistance in health care settings. Suggestions are made for needed common definitions and approaches, study areas for future research are considered, and priority investigations are identified.
ISSN:1058-4838
1537-6591
DOI:10.1086/323758